Sugi Predict

Sugi Predict / Compounds / SCHEMBL17023902

SCHEMBL17023902

SCHEMBL17023902

c1cnc(-c2nc(-c3cnc(-c4nc(-c5ncccn5)n5ccccc45)cn3)c3ccccn23)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 5/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ HIF1A Q16665 7/20 0.37
▸ EPAS1 Q99814 7/20 0.37
▸ RAD51 Q06609 2/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ BRD2 P25440 1/20 0.35
▸ BRD3 Q15059 1/20 0.35
▸ BAZ2B Q9UIF8 1/20 0.35
▸ BAZ2A Q9UIF9 1/20 0.35
▸ MAP2K3 P46734 1/20 0.34
▸ KDM4E B2RXH2 4/20 0.34
▸ ALDH1A1 P00352 4/20 0.34
▸ L3MBTL1 Q9Y468 3/20 0.34
▸ MAPT P10636 2/20 0.34
▸ HTT P42858 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17023905 0.86 BRD4 (0.43) GAAKMT2AMEN1NPSR1HPGD
SCHEMBL17023884 0.85 GAA (0.43) GAAKMT2AMEN1NPSR1HPGD
SCHEMBL17023900 0.84 KMT2A (0.52) GAAKMT2AMEN1NPSR1HPGD
SCHEMBL17023886 0.83 KMT2A (0.51) GAAKMT2AMEN1NPSR1HPGD
SCHEMBL17023876 0.83 KMT2A (0.48) GAAKMT2AMEN1NPSR1HPGD
SCHEMBL17023882 0.80 HIF1A (0.47) GAAKMT2AMEN1NPSR1HPGD
SCHEMBL17023892 0.80 KMT2A (0.49) GAAKMT2AMEN1NPSR1HPGD
SCHEMBL17023875 0.77 KMT2A (0.40) GAAKMT2AMEN1NPSR1HPGD
SCHEMBL17023873 0.76 KMT2A (0.42) GAAKMT2AMEN1NPSR1HPGD
SCHEMBL17023889 0.76 ALDH1A1 (0.38) GAAKMT2AMEN1NPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10847726-B2 Imidizo derivatives THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 2020-11-24 — — US disclosed
US-10847726-B2 Imidizo derivatives THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 2020-11-24 — — US disclosed
US-20190131538-A1 IMIDIZO DERIVATIVES THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY 2019-05-02 — — US disclosed
US-20190131538-A1 IMIDIZO DERIVATIVES THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY 2019-05-02 — — US disclosed
US-20150243896-A1 IMIDAZO DERIVATIVES ARMY, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE 2015-08-27 — — US disclosed
US-20150243896-A1 IMIDAZO DERIVATIVES ARMY, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE 2015-08-27 — — US disclosed
US-20150243896-A1 IMIDAZO DERIVATIVES ARMY, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE 2015-08-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190131538-A1 IMIDIZO DERIVATIVES IKZF1, IKZF3, IKZF2 GAA 3973/4885KMT2A 1089/4885MEN1 3752/4885
US-10847726-B2 Imidizo derivatives IKZF1, IKZF3, IKZF2 GAA 3973/4885KMT2A 1089/4885MEN1 3752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.